UniProt ID | BHE40_HUMAN | |
---|---|---|
UniProt AC | O14503 | |
Protein Name | Class E basic helix-loop-helix protein 40 | |
Gene Name | BHLHE40 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 412 | |
Subcellular Localization | Cytoplasm . Nucleus . Predominantly localized in the nucleus (PubMed:11278694). | |
Protein Description | Transcriptional repressor involved in the regulation of the circadian rhythm by negatively regulating the activity of the clock genes and clock-controlled genes. Acts as the negative limb of a novel autoregulatory feedback loop (DEC loop) which differs from the one formed by the PER and CRY transcriptional repressors (PER/CRY loop). Both these loops are interlocked as it represses the expression of PER1/2 and in turn is repressed by PER1/2 and CRY1/2. Represses the activity of the circadian transcriptional activator: CLOCK-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer by competing for the binding to E-box elements (5'-CACGTG-3') found within the promoters of its target genes. Negatively regulates its own expression and the expression of DBP and BHLHE41/DEC2. Acts as a corepressor of RXR and the RXR-LXR heterodimers and represses the ligand-induced RXRA and NR1H3/LXRA transactivation activity. May be involved in the regulation of chondrocyte differentiation via the cAMP pathway.. | |
Protein Sequence | MERIPSAQPPPACLPKAPGLEHGDLPGMYPAHMYQVYKSRRGIKRSEDSKETYKLPHRLIEKKRRDRINECIAQLKDLLPEHLKLTTLGHLEKAVVLELTLKHVKALTNLIDQQQQKIIALQSGLQAGELSGRNVETGQEMFCSGFQTCAREVLQYLAKHENTRDLKSSQLVTHLHRVVSELLQGGTSRKPSDPAPKVMDFKEKPSSPAKGSEGPGKNCVPVIQRTFAHSSGEQSGSDTDTDSGYGGESEKGDLRSEQPCFKSDHGRRFTMGERIGAIKQESEEPPTKKNRMQLSDDEGHFTSSDLISSPFLGPHPHQPPFCLPFYLIPPSATAYLPMLEKCWYPTSVPVLYPGLNASAAALSSFMNPDKISAPLLMPQRLPSPLPAHPSVDSSVLLQALKPIPPLNLETKD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MERIPSAQPPPAC --CCCCCCCCCCCCC | 36.85 | 24719451 | |
16 | Ubiquitination | PPPACLPKAPGLEHG CCCCCCCCCCCCCCC | 55.02 | - | |
37 | Phosphorylation | PAHMYQVYKSRRGIK CHHHHHHHHHHCCCC | 6.42 | 22817900 | |
38 | Acetylation | AHMYQVYKSRRGIKR HHHHHHHHHHCCCCC | 38.33 | 155373 | |
54 | Acetylation | EDSKETYKLPHRLIE CCCHHHHCCCHHHHH | 64.06 | 12432263 | |
84 | Ubiquitination | DLLPEHLKLTTLGHL HHCHHHHHCCCHHHH | 45.77 | - | |
105 | Ubiquitination | ELTLKHVKALTNLID HHHHHHHHHHHHHHH | 37.08 | - | |
117 | Ubiquitination | LIDQQQQKIIALQSG HHHHHHHHHHHHHHC | 31.57 | 2190698 | |
159 | Sumoylation | EVLQYLAKHENTRDL HHHHHHHHCCCCCCC | 49.18 | 21829689 | |
159 | Sumoylation | EVLQYLAKHENTRDL HHHHHHHHCCCCCCC | 49.18 | - | |
159 | Ubiquitination | EVLQYLAKHENTRDL HHHHHHHHCCCCCCC | 49.18 | - | |
167 | Sumoylation | HENTRDLKSSQLVTH CCCCCCCHHHHHHHH | 52.96 | - | |
167 | Sumoylation | HENTRDLKSSQLVTH CCCCCCCHHHHHHHH | 52.96 | 28112733 | |
167 | Ubiquitination | HENTRDLKSSQLVTH CCCCCCCHHHHHHHH | 52.96 | - | |
192 | Phosphorylation | GGTSRKPSDPAPKVM CCCCCCCCCCCCCCC | 60.30 | 29083192 | |
202 | Acetylation | APKVMDFKEKPSSPA CCCCCCCCCCCCCCC | 61.64 | 7709511 | |
206 | Phosphorylation | MDFKEKPSSPAKGSE CCCCCCCCCCCCCCC | 61.08 | 25394399 | |
207 | Phosphorylation | DFKEKPSSPAKGSEG CCCCCCCCCCCCCCC | 37.09 | 24719451 | |
212 | Phosphorylation | PSSPAKGSEGPGKNC CCCCCCCCCCCCCCC | 38.38 | 24719451 | |
217 | Ubiquitination | KGSEGPGKNCVPVIQ CCCCCCCCCCCHHHH | 50.75 | - | |
226 | Phosphorylation | CVPVIQRTFAHSSGE CCHHHHHHHCCCCCC | 14.59 | 28450419 | |
230 | Phosphorylation | IQRTFAHSSGEQSGS HHHHHCCCCCCCCCC | 36.29 | 28450419 | |
231 | Phosphorylation | QRTFAHSSGEQSGSD HHHHCCCCCCCCCCC | 36.16 | 28450419 | |
235 | Phosphorylation | AHSSGEQSGSDTDTD CCCCCCCCCCCCCCC | 35.64 | 28450419 | |
237 | Phosphorylation | SSGEQSGSDTDTDSG CCCCCCCCCCCCCCC | 42.45 | 28450419 | |
239 | Phosphorylation | GEQSGSDTDTDSGYG CCCCCCCCCCCCCCC | 42.36 | 28450419 | |
241 | Phosphorylation | QSGSDTDTDSGYGGE CCCCCCCCCCCCCCC | 33.87 | 28450419 | |
243 | Phosphorylation | GSDTDTDSGYGGESE CCCCCCCCCCCCCCC | 35.69 | 23090842 | |
245 | Phosphorylation | DTDTDSGYGGESEKG CCCCCCCCCCCCCCC | 26.38 | 23090842 | |
249 | Phosphorylation | DSGYGGESEKGDLRS CCCCCCCCCCCCCCC | 48.13 | 23090842 | |
251 | Ubiquitination | GYGGESEKGDLRSEQ CCCCCCCCCCCCCCC | 67.99 | - | |
262 | Ubiquitination | RSEQPCFKSDHGRRF CCCCCCCCCCCCCCC | 62.79 | - | |
279 | Sumoylation | GERIGAIKQESEEPP HHHHHCHHCCCCCCC | 47.69 | 25114211 | |
279 | Sumoylation | GERIGAIKQESEEPP HHHHHCHHCCCCCCC | 47.69 | - | |
288 | Sumoylation | ESEEPPTKKNRMQLS CCCCCCCCCCCCCCC | 54.55 | 28112733 | |
380 | Methylation | APLLMPQRLPSPLPA CCCCCCCCCCCCCCC | 42.57 | - | |
383 | Phosphorylation | LMPQRLPSPLPAHPS CCCCCCCCCCCCCCC | 43.60 | 28450419 | |
393 | Phosphorylation | PAHPSVDSSVLLQAL CCCCCCCHHHHHHHH | 21.86 | 27251275 | |
394 | Phosphorylation | AHPSVDSSVLLQALK CCCCCCHHHHHHHHC | 16.60 | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
243 | S | Phosphorylation | Kinase | CK1A | P48729 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:25202122 |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXW11 | Q9UKB1 | PMID:25202122 |
- | K | Ubiquitination | E3 ubiquitin ligase | VHL | P40337 | PMID:11278694 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BHE40_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BHE40_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...